{"schema_version":"secwatch.filing_event.v1","accession":"0001555280-23-000148","form_type":"8-K","ticker":"ZTS","cik":"0001555280","company_name":"Zoetis Inc.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.370685+00:00","generated_at":"2026-06-15T21:51:08.463814+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Zoetis Q1 revenue $2.0B (+1% reported, +4% operational); adj. EPS $1.31, down 1% operationally","bullets":["Reported net income $552M ($1.19 diluted EPS), down 7% and 6% YoY respectively.","Adjusted net income $607M ($1.31 diluted EPS); adjusted diluted EPS down 1% operationally.","International segment revenue grew 10% operationally; U.S. segment revenue declined 1%.","Full-year 2023 guidance maintained: revenue $8.575-8.725B, adj. diluted EPS $5.34-5.44.","U.S. companion animal sales fell 7% due to distributor de-stocking; livestock sales up 15%."],"urls":{"canonical":"https://secwatch.observer/filing/0001555280-23-000148","json":"https://secwatch.observer/filing/0001555280-23-000148.json","markdown":"https://secwatch.observer/filing/0001555280-23-000148.md","text":"https://secwatch.observer/filing/0001555280-23-000148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1555280/000155528023000148/0001555280-23-000148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1555280/000155528023000148/zts-20230504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T21:51:08.463814+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ae319d61715e2abd39fb5aa9c53e73945e2de362","claim":"Zoetis Inc. reported first quarter of 2023 results: revenue $2.0 billion, net income $552 million, or $1.19 per diluted share. Guidance reaffirmed.","evidence_excerpt":"Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023 • Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted Net Income for First Quarter 2023 • Reports Adjusted Net Income of $607 Million, or Adjusted Diluted EPS of $1.31, for First Quarter 2023 • Maintains Full Year 2023 Revenue Guidance of $8.575 - $8.725 Billion, with Diluted EPS of $5.03 to $5.14 on a Reported Basis, or $5.34 to $5.44 on an Adjusted Basis","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1555280/000155528023000148/0001555280-23-000148-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter of 2023"},{"label":"Revenue","value":"$2.0 billion"},{"label":"Net income","value":"$552 million, or $1.19 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}